Oxford BioMedica wins big contract for Novartis cell therapy

LONDON (Reuters) – Novartis has signed a major contract with Oxford BioMedica that could earn the British company more than $100 million (77.32 million pounds) over three years for supplying the Swiss drugmaker with material for its novel cell therapy CTL019.

from Reuters: Top News http://uk.reuters.com/article/uk-oxford-biomedica-novartis-idUKKBN19R0NQ?feedType=RSS&feedName=topNews

Advertisements

Author: Frozen Pension

Our aim when we set up was to help people like you track down their frozen pensions with the greatest of ease. Tracking a lost or frozen pension can often be a complicated process for people who are unfamiliar with the system, and we realised that we could provide the help and expert support that people need.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s